Ledger.Open graph →

SEC Form D · filed June 27, 2016

Sun BioPharma, Inc

Offering

$5.0M

Sold

$2.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WACONIA, MN

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Dalvir S. Gill · WACONIA, MNDirector Paul W. Schaffer · WACONIA, MNDirector David B. Kaysen · WACONIA, MNExec · Director Suzanne T. Gagnon · WACONIA, MNDirector Michael T. Cullen · WACONIA, MNExec · Director Jeffrey S. Mathiesen · WACONIA, MNDirector D. R. Schemel · WACONIA, MNDirector Scott R. Kellen · WACONIA, MNExec J. R. Paulson · WACONIA, MNDirector David Bree · Grand Cayman, Cayman IslandsDirector Colin Mackay · GEORGE TOWN, Grand Cayman, Cayman IslandsDirector Jan E. Frogg · Grand Cayman, Cayman IslandsDirector Michael A. Harmon · Everett, WAExec · Director Thomas P. Hoban, Jr · Everett, WAExec Carl Y. Baggett · Dallas, TXDirector Jonathan Roney · GEORGE TOWN, Grand Cayman, Cayman IslandsDirector Mark E. Stabile · Grand Cayman, Cayman IslandsExec · Director Shawn A. Hoban · Everett, WADirector Michael Wasser · Seattle, WADirector Gregory Kris · Chicago, ILDirector Monroe Capital, Inc · Rochester, NYExec · Director Bridget Martin · Rochester, NYDirector Paul Adams · Rochester, NYDirector John W. Rosenthal · Mishawaka, INExec Sarah Blankinship · Seattle, WAExec · Director J. R. Paulson · WACONIA, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗